Compounds > galactosamine
Page last updated: 2024-08-22

galactosamine and losartan potassium

galactosamine has been researched along with losartan potassium in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bosch, E; Chamuleau, RA; Dinkelaar, RB; Engels, EY; Hart, AA; Schoemaker, LP1
Abshagen, K; Eipel, C; Klemm, K; Le Minh, K; Menger, MD; Vollmar, B1
Avlas, O; Ben-Ari, Z; Cheporko, Y; Greif, F; Hochhauser, E; Pappo, O; Ravid, A; Shapiro, R; Sharon, E; Zilbermints, V1
Chen, H; Chen, LN; He, Y; Ji, WJ; Li, HY; Liu, JB; Liu, X; Wang, B; Yang, XF1
Ai, Q; Ao, JE; Duan, R; Ge, P; Gong, X; Lin, L; Zhang, L1

Other Studies

5 other study(ies) available for galactosamine and losartan potassium

ArticleYear
Metabolic studies on erythropoietin (EP): II. The role of liver and kidney in the metabolism of Ep.
    Experimental hematology, 1981, Volume: 9, Issue:7

    Topics: Alanine Transaminase; Animals; Erythropoietin; Galactosamine; Glucose; In Vitro Techniques; Kidney; Liver; Male; Nephrectomy; Perfusion; Rats

1981
Attenuation of inflammation and apoptosis by pre- and posttreatment of darbepoetin-alpha in acute liver failure of mice.
    The American journal of pathology, 2007, Volume: 170, Issue:6

    Topics: Animals; Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Caspase 3; Cytokines; Darbepoetin alfa; Erythropoietin; Galactosamine; Hematinics; Inflammation; Lipopolysaccharides; Liver; Liver Failure, Acute; Male; Mice; Mice, Inbred C57BL; Proliferating Cell Nuclear Antigen

2007
Erythropoietin increases survival and attenuates fulminant hepatic failure injury induced by D-galactosamine/lipopolysaccharide in mice.
    Transplantation, 2011, Jul-15, Volume: 92, Issue:1

    Topics: Alanine Transaminase; Animals; Apoptosis; Aspartate Aminotransferases; Disease Models, Animal; Erythropoietin; Galactosamine; Humans; Interleukin-1beta; JNK Mitogen-Activated Protein Kinases; Kaplan-Meier Estimate; Lipopolysaccharides; Liver; Liver Failure, Acute; Mice; Mice, Inbred C57BL; NF-kappa B; Recombinant Proteins; Tumor Necrosis Factor-alpha

2011
Hepatoprotective effects of erythropoietin on D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure in mice.
    Molecular medicine reports, 2014, Volume: 10, Issue:1

    Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Disease Models, Animal; Epoetin Alfa; Erythropoietin; Galactosamine; Glutathione Peroxidase; Lipopolysaccharides; Liver; Liver Failure, Acute; Malondialdehyde; Mice; Mice, Inbred BALB C; Phosphatidylinositol 3-Kinase; Protective Agents; Receptors, Erythropoietin; Recombinant Proteins; RNA, Messenger; Superoxide Dismutase

2014
Metformin suppresses intrahepatic coagulation activation in mice with lipopolysaccharide/D‑galactosamine‑induced fulminant hepatitis.
    Molecular medicine reports, 2015, Volume: 12, Issue:4

    Topics: Animals; Anti-Inflammatory Agents; Blood Coagulation; Disease Models, Animal; Erythropoietin; Galactosamine; Hepatitis; Hypoglycemic Agents; Hypoxia-Inducible Factor 1, alpha Subunit; Inflammation; Interleukin-6; Lactic Acid; Lipopolysaccharides; Liver; Matrix Metalloproteinase 3; Metformin; Mice; NF-kappa B; Plasminogen Activator Inhibitor 1; RNA, Messenger; Thromboplastin; Up-Regulation; Vascular Endothelial Growth Factor A

2015